drug

concizumab

1 story · latest Oct 28, 2026

Follow concizumab. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Dec 2024 · BLA761315, BLA761428
Brand: Alhemo
Trials: 4 registered trials in coverage

Relationships

Developed by Novo Nordisk A/S

Timeline

Novo Nordisk: BARI-STEP semaglutide trial results posted; two new Phase 1 studies registered

Oct 28Weekly roundup, 7 itemsconcizumab denecimig

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.